Pediatr. praxi. 2022;23(5):336-338

Do we know the role of human milk oligosaccharides?

doc. Ing. ©árka Musilová, Ph.D., prof. Ing. Eva Vlková, Ph.D., Ing. Iva Mrvíková, Ing. ©těpánka Kozáková
Katedra mikrobiologie, výľivy a dietetiky, Fakulta agrobiologie, potravinových a přírodních zdrojů, Česká zemědělská univerzita v Praze

The oligosaccharides contained in breast milk play an irreplaceable role in the proper development of the newborn and perform a number of biological functions, although they are often neglected. From a nutritional point of view, they are not very important for infants, but their main benefits are their ability to influence the development of the infant's nervous system and immunity due to their prebiotic, antimicrobial, antiadhesive and antibiofilm properties. Unfortunately, the lack of information about them hinders us in their therapeutic use.

Keywords: human milk oligosaccharides, antimicrobial properties, antibiofilm properties, prebiotics.

Accepted: October 4, 2022; Published: October 11, 2022  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Musilová ©, Vlková E, Mrvíková I, Kozáková ©. Do we know the role of human milk oligosaccharides? Pediatr. praxi. 2022;23(5):336-338.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Organization WH. Report of the expert consultation of the optimal duration of exclusive breastfeeding. Geneva, Switzerland: World health organisation; 28-30 March 2001.
    2. Lönnerdal B. Infant formula and infant nutrition: bioactive proteins of human milk and implications for composition of infant formulas. The American journal of clinical nutrition. 2014;99(3):712S-717S. Go to original source... Go to PubMed...
    3. Vass RA, et al. Distribution of bioactive factors in human milk samples. International breastfeeding journal. 2019;14(1):1-10. Go to original source... Go to PubMed...
    4. Cregan MD, et al. Identification of nestin-positive putative mammary stem cells in human breastmilk. Cell and tissue research. 2007;329(1):129-136. Go to original source... Go to PubMed...
    5. Meki A-RM, et al. Interleukins-6,-8 and-10 and tumor necrosis factor-alpha and its soluble receptor I in human milk at different periods of lactation. Nutrition research. 2003;23(7): 845-855. Go to original source...
    6. Savel'ev AN, et al. Amylolytic activity of IgG and sIgA immunoglobulins from human milk. Clinica chimica acta. 2001;314(1-2):141-152. Go to original source... Go to PubMed...
    7. Coppa GV, et al. Changes in carbohydrate composition in human milk over 4 months of lactation. Pediatrics. 1993;91(3): 637-641. Go to original source... Go to PubMed...
    8. Nijman RM, et al. Characterization and quantification of oligosaccharides in human milk and infant formula. Journal of agricultural and food chemistry. 2018;66(26):6851-6859. Go to original source... Go to PubMed...
    9. Gabrielli O, et al. Preterm milk oligosaccharides during the first month of lactation. Pediatrics. 2011;128(6):e1520-e1531. Go to original source... Go to PubMed...
    10. Bode LE, Jantscher-Krenn. Structure-function relationships of human milk oligosaccharides. Advances in Nutrition: An International Review Journal. 2012;3(3):383S-391S. Go to original source... Go to PubMed...
    11. Thurl S, et al. Systematic review of the concentrations of oligosaccharides in human milk. Nutrition Reviews. 2017;75(11):920-933. Go to original source... Go to PubMed...
    12. Erney R, et al. Human Milk Oligosaccharides, in Bioactive Components of Human Milk. Berlin: Springer; 2001:285-297. Go to original source...
    13. Thurl S, et al. Detection of four human milk groups with respect to Lewis blood group dependent oligosaccharides. Glycoconjugate journal. 1997;14(7):795-799. Go to original source... Go to PubMed...
    14. Stahl B, et al. Detection of four human milk groups with respect to Lewis-bloodgroup-dependent oligosaccharides by serologic and chromatographic analysis. In Bioactive Components of Human Milk. Berlin: Springer; 2001:299-306. Go to original source...
    15. Thurl S, et al. Variation of human milk oligosaccharides in relation to milk groups and lactational periods. British Journal of Nutrition. 2010;104(9):1261. Go to original source... Go to PubMed...
    16. Rudloff S, et al. Urinary excretion of in vivo 13 C-labelled milk oligosaccharides in breastfed infants. British Journal of Nutrition. 2012;107(07):957-963. Go to original source... Go to PubMed...
    17. Ruhaak LR, et al. Detection of milk oligosaccharides in plasma of infants. Analytical and bioanalytical chemistry. 2014; 406(24):5775-5784. Go to original source... Go to PubMed...
    18. Goehring KC, et al. Direct evidence for the presence of human milk oligosaccharides in the circulation of breastfed infants. PloS one. 2014;9(7):e101692. Go to original source... Go to PubMed...
    19. Dotz V, Kunz C. Letter to the editor regarding "A quantitative and comprehensive method to analyze human milk oligosaccharide structures in the urine and feces of infants". Analytical and Bioanalytical Chemistry. 2013;405(24): 7897-7897. Go to original source... Go to PubMed...
    20. Bode L. Human milk oligosaccharides: prebiotics and beyond. Nutrition reviews. 2009;67(s2):S183-S191. Go to original source... Go to PubMed...
    21. Gnoth MJ, et al. Human milk oligosaccharides are minimally digested in vitro. The Journal of nutrition. 2000;130(12): 3014-3020. Go to original source... Go to PubMed...
    22. Jantscher-Krenn E, et al. The human milk oligosaccharide disialyllacto-N-tetraose prevents necrotising enterocolitis in neonatal rats. Gut. 2012;61(10):1417-1425. Go to original source... Go to PubMed...
    23. Moore RE, Xu LL, Townsend SD. Prospecting human milk oligosaccharides as a defense against viral infections. ACS infectious diseases. 2021;7(2):254-263. Go to original source... Go to PubMed...
    24. Sela DA, et al. An infant-associated bacterial commensal utilizes breast milk sialyloligosaccharides. Journal of Biological Chemistry. 2011;286(14):11909-11918. Go to original source... Go to PubMed...
    25. Sela DA, et al. Bifidobacterium longum subsp infantis ATCC 15697 alpha-Fucosidases Are Active on Fucosylated Human Milk Oligosaccharides. Applied and Environmental Microbiology. 2012;78(3):795-803. Go to original source... Go to PubMed...
    26. Musilova S, et al. Assessment of the synbiotic properites of human milk oligosaccharides and Bifidobacterium longum subsp. infantis in vitro and in humanised mice. Beneficial Microbes. 2017:1-9. Go to original source... Go to PubMed...
    27. Buneąová V, et al. Growth of infant fecal bacteria on commercial prebiotics. Folia Microbiologica. 2012;57(4): 273-275. Go to original source... Go to PubMed...
    28. Vivatvakin B, et al. Effect of a whey-predominant starter formula containing LCPUFAs and oligosaccharides (FOS/GOS) on gastrointestinal comfort in infants. Asia Pacific journal of clinical nutrition. 2010;19(4):473-480. Go to PubMed...
    29. Bode L, et al. Human milk oligosaccharides reduce platelet-neutrophil complex formation leading to a decrease in neutrophil β 2 integrin expression. Journal of Leukocyte Biology. 2004;76(4):820-826. Go to original source... Go to PubMed...
    30. Bode L, et al. Inhibition of monocyte, lymphocyte, and neutrophil adhesion to endothelial cells by human milk oligosaccharides. Thrombosis and haemostasis stutt gart. 2004;92:1402-1410. Go to original source... Go to PubMed...
    31. Morrow AL, et al. Human-milk glycans that inhibit pathogen binding protect breast-feeding infants against infectious diarrhea. The Journal of nutrition. 2005;135(5):1304-1307. Go to original source... Go to PubMed...
    32. Ruiz-Palacios GM, et al. Campylobacter jejuni binds intestinal H (O) antigen (Fucα1, 2Galβ1, 4GlcNAc), and fucosyloligosaccharides of human milk inhibit its binding and infection. Journal of biological chemistry. 2003;278(16): 14112-14120. Go to original source... Go to PubMed...
    33. Vandenplas Y, et al. Human milk oligosaccharides: 2'-fucosyllactose (2'-FL) and lacto-N-neotetraose (LNnT) in infant formula. Nutrients. 2018;10(9):1161. Go to original source... Go to PubMed...
    34. Puccio G, et al. Effects of infant formula with human milk oligosaccharides on growth and morbidity: a randomized multicenter trial. Journal of pediatric gastroenterology and nutrition. 2017;64(4):624. Go to original source... Go to PubMed...
    35. Cheng L, et al. Human milk oligosaccharides and its acid hydrolysate LNT2 show immunomodulatory effects via TLRs in a dose and structure-dependent way. Journal of Functional Foods. 2019;59:174-184. Go to original source...
    36. Kong C, et al. Modulation of intestinal epithelial glycocalyx development by human milk oligosaccharides and non-digestible carbohydrates. Molecular nutrition & food research. 2019;63(17):1900303. Go to original source... Go to PubMed...
    37. Salli K, et al. The effect of 2'-fucosyllactose on simulated infant gut microbiome and metabolites; a pilot study in comparison to GOS and lactose. Scientific reports. 2019;9(1):1-15. Go to original source... Go to PubMed...
    38. Kunz C, et al. Oligosaccharides in human milk: structural, functional, and metabolic aspects. Annual review of nutrition. 2000;20(1):699-722. Go to original source... Go to PubMed...
    39. Bode L. Human milk oligosaccharides: structure and functions. Milk, Mucosal Immunity and the Microbiome: Impact on the Neonate. 2020;94:115-123. Go to original source... Go to PubMed...
    40. Bode L. Human milk oligosaccharides: every baby needs a sugar mama. Glycobiology. 2012;22(9):1147-1162. Go to original source... Go to PubMed...
    41. Duska-McEwen G, et al. Human milk oligosaccharides enhance innate immunity to respiratory syncytial virus and influenza in vitro. Food and Nutrition Sciences. 2014. Go to original source...
    42. Zevgiti S, et al. Sialic acid and sialyl-lactose glyco-conjugates: design, synthesis and binding assays to lectins and swine influenza H1N1 virus. Journal of Peptide Science. 2012;18(1):52-58. Go to original source... Go to PubMed...
    43. Triantis V, Bode L, Neerven van RJ. Immunological effects of human milk oligosaccharides. Frontiers in pediatrics. 2018: 190. Go to original source... Go to PubMed...
    44. Shang J, et al. Identifying human milk glycans that inhibit norovirus binding using surface plasmon resonance. Glycobiology. 2013;23(12):1491-1498. Go to original source... Go to PubMed...
    45. Bode L. Human milk oligosaccharides at the interface of maternal-infant health. Breastfeeding Medicine. 2018; 13(S1):S-7-S-8. Go to original source... Go to PubMed...
    46. Autran CA, et al. Human milk oligosaccharide composition predicts risk of necrotising enterocolitis in preterm infants. Gut. 2018;67(6): p. 1064-1070. Go to original source... Go to PubMed...
    47. Ackerman DL. Human Milk Oligosaccharides as a Defense Against Group B Streptococcus. USA: Vanderbilt University; 2018.
    48. Craft KM, Gaddy JA, Townsend SD. Human milk oligosaccharides (HMOs) sensitize group B Streptococcus to clindamycin, erythromycin, gentamicin, and minocycline on a strain specific basis. ACS Chemical Biology. 2018;13(8): 2020-2026. Go to original source... Go to PubMed...
    49. Ackerman DL, et al. Antimicrobial and antibiofilm activity of human milk oligosaccharides against Streptococcus agalactiae, Staphylococcus aureus, and Acinetobacter baumannii. ACS infectious diseases. 2017;4(3):315-324. Go to original source... Go to PubMed...

    Return to the content


    Pediatrics for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.